Skip to main content

View full-text article in PMC

letter

. 2022 Nov 21;115(2):222–223. doi: 10.1093/jnci/djac213

Table 1.

Randomized trials: recurrence risk among women with early-stage breast cancer by menopausal hormone therapy^a

	Hormone therapy use		No hormone
	Total	Breast cancer recurrence	Total	Breast cancer recurrence
Marsden (Col 2005) (6)	51	2	49	1
HABITS (Holmberg 2008) (3)	221	39	221	17
Stockholm (Fahlen 2013) (4)	188	60	190	48
Total	460	101	460	66

^a

Pooling data across the 3 trials yields a relative risk of 1.53 (95% confidence interval = 1.15 to 2.03).